ArticleBioinformatics (Oxford, England)2026
Drug target prediction from perturbation transcriptomics via a biological function-guided hypergraph siamese network.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationUnderstanding how small molecules modulate cellular states remains a critical challenge in drug discovery. The advent of perturbation transcriptomics offers new avenues for elucidating drug-target interactions by capturing cellular transcriptional responses to perturbations.
resultsIn this study, we propose BioHSNet, a biological function-guided hypergraph siamese network for inferring drug-target interactions from perturbation transcriptomics. BioHSNet utilizes hyperedge representations of functionally grouped gene expression to capture higher-order functional relationships, and integrates compound structural information into the model to bridge chemical structure and functional response. Experimental results demonstrate that BioHSNet outperforms other transcriptome-based methods on the Broad Institute's L1000 datasets, particularly in cold start scenarios. The case study further demonstrates its practical utility for target prediction and drug screening. AVAILABILITY AND IMPLEMENTATION: The source code is available at https://github.com/Zxinyizhang/BioHSNet.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.